Christopher Powala
2014
In 2014, Christopher Powala earned a total compensation of $482.6K as Chief Operating Officer at Aclaris Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $90,228 |
|---|---|
| Option Awards | $79,875 |
| Salary | $300,760 |
| Other | $11,708 |
| Total | $482,571 |
Powala received $300.8K in salary, accounting for 62% of the total pay in 2014.
Powala also received $90.2K in non-equity incentive plan, $79.9K in option awards and $11.7K in other compensation.
Rankings
In 2014, Christopher Powala's compensation ranked 10,389th out of 13,032 executives tracked by ExecPay. In other words, Powala earned more than 20.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,389 out of 13,032 | 20th |
Division Manufacturing | 3,948 out of 4,966 | 21st |
Major group Chemicals And Allied Products | 1,360 out of 1,686 | 19th |
Industry group Drugs | 1,090 out of 1,365 | 20th |
Industry Pharmaceutical Preparations | 834 out of 1,043 | 20th |
Source: SEC filing on May 20, 2016.
Powala's colleagues
We found two more compensation records of executives who worked with Christopher Powala at Aclaris Therapeutics in 2014.